您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > CDK7/9-IN-1
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
CDK7/9-IN-1
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
CDK7/9-IN-1图片
CAS NO:2747919-19-1
包装与价格:
包装价格(元)
100mg电议
250mg电议
500mg电议

产品介绍
CDK7/9-IN-1 是一种细胞周期蛋白依赖性激酶 7/9 (CDK7/9) 抑制剂。CDK7/9-IN-1 选择性抑制 CDK7。CDK7/9-IN-1 在非预孵育和预孵育 3 小时后抑制 CDK7,IC50分别为 0.0656 μM 和 0.00574 μM。 CDK7/9-IN-1 在预孵育 3 小时后抑制 CDK9,IC50为 2.14 μM。 CDK7/9-IN-1可用于癌症研究。
生物活性

CDK7/9-IN-1 is acyclin-dependent kinases7/9 (CDK7/9) inhibitor. CDK7/9-IN-1 selectively inhibitsCDK7overCDK9. CDK7/9-IN-1 inhibitsCDK7withIC50s of 0.0656 μM and 0.00574 μM without pre-incubation and after 3 hours pre-incubation, respectively. CDK7/9-IN-1 inhibitsCDK9with anIC50of 2.14 μM after 3 hours pre-incubation. CDK7/9-IN-1 can be used for the research ofcancer[1].

IC50& Target[1]

CDK7

5.74-65.6 nM (IC50)

CDK9

2.14 μM (IC50)

体外研究
(In Vitro)

CDK7/9-IN-1 (example 8; 0.001-20 μM; 4 h) inhibits CDK7 with an relative IC50of 0.0262 μM for phospho-carboxyl terminal domain (Rbp2) (Ser5) in HCT116 cells[1].
CDK7/9-IN-1 (0.001-20 μM; 4 h) inhibits CDK9 with an IC50of 2.59 μM for phospho-carboxyl terminal domain (Rbp2) (Ser2) in HCT116 cells[1].
CDK7/9-IN-1 (0.001-20 μM; 4 h) inhibits cMyc with an relative IC50of 0.0138 μM in HCT116 cells[1].
CDK7/9-IN-1 (20 μΜ, 2 μΜ, and 0.2 μΜ; 1 h) shows excellent selectivity against the 468 protein kinases panel. CDK7/9-IN-1 shows approximately 96% inhibition against CDK7[1].

分子量

479.54

Formula

C24H32F3N5O2

CAS 号

2747919-19-1

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.